UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder
Findings of the study showed safety (no treatment-related serious adverse events or suicidality) with psilocybin and suggested efficacy, with a significant reduction in depression severity scores from baseline to posttreatment. Further investigation is warranted.
Assessment of psilocybin therapy for patients with cancer and major depression disorder
This study uses a potentially more efficient/cost-effective 1-to-1 (rather than the currently standard 2-to-1) therapist-to-patient ratio.
Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients
Findings suggest that psilocybin-assisted therapy facilitates psycho-social-spiritual growth as measured by the NIH-HEALS and its three factors.
Psychedelics for patients with cancer: A comprehensive literature review
Psychedelics have a unique mechanism of action that might be well suited for treating anxiety and depression associated with cancer.
'Magic' of psychedelics: Easing the trauma of terminal illness
A growing body of evidence shows that psilocybin is safe and can relieve symptoms of depression and end-of-life demoralization in people with cancer and other life-threatening conditions.
The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research.
The majority of patient experiences were positive, centering on death acceptance, reflection & broadened spirituality.
Cancer healthcare workers’ perceptions toward psychedelic-assisted therapy: A preliminary investigation
Cancer healthcare workers’ perceptions toward psychedelic-assisted therapy